Quick Answer
Pediatrix Medical Group, Inc. reported Net Income of $165.39 million for fiscal year 2025.
Pediatrix Medical Group, Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Net Income | $165.39M +266.9% |
-$99.07M -64.0% |
-$60.41M -191.1% |
$66.33M -49.3% |
$130.96M +116.4% |
-$796.49M +46.8% |
| Diluted EPS | $1.94 +263.0% |
-$1.19 -63.0% |
-$0.73 -192.4% |
$0.79 -48.4% |
$1.53 +116.0% |
-$9.55 +46.4% |
| Total Assets | $2.25B +4.4% |
$2.15B -3.0% |
$2.22B -5.5% |
$2.35B -13.8% |
$2.72B -18.7% |
$3.35B -19.2% |
| Cash and Equivalents | $375.24M +63.2% |
$229.94M +213.9% |
$73.26M +645.7% |
$9.82M -97.5% |
$387.39M -65.5% |
$1.12B +941.8% |
| Stockholders Equity | $865.85M +13.2% |
$764.94M -9.9% |
$849.06M -4.8% |
$891.63M -0.5% |
$896.49M +19.9% |
$747.49M -50.1% |
| Operating Income | $208.81M +403.9% |
-$68.71M -1038.6% |
$7.32M -95.8% |
$172.69M -14.9% |
$202.92M +106.8% |
$98.13M -42.9% |
| Shares Outstanding | 82.98M -3.4% |
85.87M +2.2% |
84.02M +1.3% |
82.95M -4.0% |
86.42M +1.0% |
85.59M +1.6% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Net Income | September 30, 2025 | $71.71M | +268.8% | +82.6% |
| Diluted EPS | September 30, 2025 | $0.84 | +265.2% | +82.6% |
| Total Assets | September 30, 2025 | $2.20B | +5.9% | +4.6% |
| Cash and Equivalents | September 30, 2025 | $340.06M | +227.5% | +51.3% |
| Stockholders Equity | September 30, 2025 | $890.67M | +21.6% | +6.8% |
| Operating Income | September 30, 2025 | $68.05M | +101.2% | +13.7% |
| Shares Outstanding | September 30, 2025 | 85.83M | -0.0% | -1.2% |
- Pediatrix Medical Group, Inc. reported Net Income of $165.39 million for fiscal year 2025.
- Pediatrix Medical Group, Inc. showed an increase of +266.9% in Net Income compared to the prior fiscal year.
- Pediatrix Medical Group, Inc. reported Diluted EPS of $1.94 per share for fiscal year 2025.
- Pediatrix Medical Group, Inc. showed an increase of +263.0% in Diluted EPS compared to the prior fiscal year.
- Pediatrix Medical Group, Inc. reported Total Assets of $2.25 billion for fiscal year 2025.
- Pediatrix Medical Group, Inc. showed an increase of +4.4% in Total Assets compared to the prior fiscal year.
- Pediatrix Medical Group, Inc. reported Cash and Equivalents of $375.24 million for fiscal year 2025.
- Pediatrix Medical Group, Inc. showed an increase of +63.2% in Cash and Equivalents compared to the prior fiscal year.
- Pediatrix Medical Group, Inc. reported Stockholders Equity of $865.85 million for fiscal year 2025.
- Pediatrix Medical Group, Inc. showed an increase of +13.2% in Stockholders Equity compared to the prior fiscal year.
- Pediatrix Medical Group, Inc. reported Operating Income of $208.81 million for fiscal year 2025.
- Pediatrix Medical Group, Inc. showed an increase of +403.9% in Operating Income compared to the prior fiscal year.
- Pediatrix Medical Group, Inc. reported Shares Outstanding of 82.98 million shares for fiscal year 2025.
- Pediatrix Medical Group, Inc. showed a decrease of -3.4% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: